Total de visites
| Visites | |
|---|---|
| Trifluridine/tipiracil ... | 48 |
Total de visites per mes
| d’octubre 2023 | de novembre 2023 | de desembre 2023 | de gener 2024 | de febrer 2024 | de març 2024 | d’abril 2024 | |
|---|---|---|---|---|---|---|---|
| Trifluridine/tipiracil ... | 0 | 4 | 0 | 1 | 0 | 1 | 2 |
Total de descàrregues del fitxer
| Visites | |
|---|---|
| trifluridine_tipiracil_combination_oxaliplatin_either_bevacizumab_nivolumab_metastatic_colorectal_cancer_a_dose_expansion_phase_i_study_2021_material_suplementari5.pdf | 9 |
| trifluridine_tipiracil_combination_oxaliplatin_either_bevacizumab_nivolumab_metastatic_colorectal_cancer_a_dose_expansion_phase_i_study_2021.pdf | 7 |
| trifluridine_tipiracil_combination_oxaliplatin_either_bevacizumab_nivolumab_metastatic_colorectal_cancer_a_dose_expansion_phase_i_study_2021_material_suplementari3.pdf | 7 |
| trifluridine_tipiracil_combination_oxaliplatin_either_bevacizumab_nivolumab_metastatic_colorectal_cancer_a_dose_expansion_phase_i_study_2021_material_suplementari2.pdf | 4 |
| trifluridine_tipiracil_combination_oxaliplatin_either_bevacizumab_nivolumab_metastatic_colorectal_cancer_a_dose_expansion_phase_i_study_2021_material_suplementari6.pdf | 3 |
| trifluridine_tipiracil_combination_oxaliplatin_either_bevacizumab_nivolumab_metastatic_colorectal_cancer_a_dose_expansion_phase_i_study_2021_material_suplementari7.pdf | 3 |
| trifluridine_tipiracil_combination_oxaliplatin_either_bevacizumab_nivolumab_metastatic_colorectal_cancer_a_dose_expansion_phase_i_study_2021_material_suplementari1.pdf | 3 |
| trifluridine_tipiracil_combination_oxaliplatin_either_bevacizumab_nivolumab_metastatic_colorectal_cancer_a_dose_expansion_phase_i_study_2021_material_suplementari4.pdf | 3 |
Visites per país
| Visites | |
|---|---|
| Estats Units | 30 |
| Suècia | 5 |
| Alemanya | 3 |
| Espanya | 3 |
| Índia | 2 |
| Bèlgica | 1 |
| Brasil | 1 |
| França | 1 |
| Irlanda | 1 |
| Rússia | 1 |
Visites per ciutat
| Visites | |
|---|---|
| Chandler | 7 |
| Ashburn | 3 |
| Barcelona | 2 |
| Phoenix | 2 |
| Boardman | 1 |
| Brussels | 1 |
| Chennai | 1 |
| Dublin | 1 |
| Los Angeles | 1 |
| Moscow | 1 |